Series B momentum Carta Healthcare has secured a significant Series B1 funding round totaling $18.25 million in May 2025, backed by a wide consortium of health system investors and venture partners, signaling strong growth potential and a broad validation of its AI-driven clinical data management platform.

Hospital and system expansion With active clients like Mass General Brigham and Memorial Hermann Health System through diverse investor participation, there is clear traction among large hospitals and health systems, suggesting opportunities to upsell across multidisciplinary departments and additional facilities within these networks.

Awarded AI leadership Recognition as Best Use of AI in Healthcare by multiple awards underscores credibility in AI-enabled data abstraction, which can be leveraged to approach health systems prioritizing AI investments and innovation-driven efficiency gains.

Hybrid intelligence value Carta combines AI with expert clinicians to deliver accurate, actionable data at reduced costs and improved speed, presenting a strong value proposition for hospitals seeking to scale data abstraction for registries, quality reporting, and outcome analytics.

New client acquisition Recent signings, such as Fivos Inc., demonstrate the model of expanding into niche vascular registries and specialty datasets, indicating cross-sell potential into other clinical data domains and broader registry partnerships within existing customers.